WebFeb 3, 2024 · Divi's Laboratories Ltd. Quarterly Results and Financial Performance as of today Competitors/Peers Quarterly Results Annual Results Balance Sheet Financial Ratios Cash Flow Documents Earnings Calls Annual Reports Search Inside the pdf : 08 Feb, 2024 BSE INDIA DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation … WebDivi’s Lab Q3FY23 preview: Consolidated net profit to likely drop 44% YoY 12.08.2024 Divi's Q1 Poll Solid profit, revenue growth on cards, but costs could dent margin
Divi
WebAnalyse annual and quarterly Income statement of Divi's Laboratories. Divi's Laboratories Ltd revenue, total costs and net profit on Tickertape. ... Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange. FY 2013. Annual report. PDF. FY 2014. Annual report. PDF. WebAug 10, 2024 · (Mint) Divi's Laboratories reported an 80.61% rise in consolidated net profit at ₹ 492.06 crore for June quarter 2024 mainly on account of robust sales Divi’s sales grew 49% year on year to ₹... itunes ile format atma
Divi
WebMar 19, 2024 · View 27 reports from 9 analysts offering long term price targets for Divi's Laboratories Ltd.. Divi's Laboratories Ltd. has an average target of 3221.62. The consensus estimate represents an upside of 14.11% from the last price of 2823.35. Reco - This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold) WebDivi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered … WebThe Yearly Results page of Divi's Laboratories Ltd. presents the key annual result items, its comparison with the sector peers and its Annual Results for the last five years. TOTAL INCOME 31.04 % Rs 8,991.08Cr. PEER RANGE 0.00 16,543.90 EBIT 39.89 % Rs 3,677.17Cr. PEER RANGE -190.07 3,677.17 PAT 50.84 % Rs 2,948.54Cr. PEER … netflix movies the whale